Elanco is to become the second largest global animal health company after its parent business Eli Lilly agreed to purchase Novartis Animal Health.The all-cash transaction will cost Lilly $5.4 billion and represents the largest ever standalone acquisition in an...

US pet spending rises 4.5% in 2013

US spending on pets grew by 4.5% in 2013 to reach a record $55.7 billion, according to the American Pet Products Association (APPA).The Connecticut-based APPA said the figure indicated the US pet market place c...

Climate change report calls for better food animal productivity

The latest report from the Intergovernmental Panel on Climate Change (IPCC) warns that warming of the global climate system is unequivocal, and has implications for food security and human and animal health.The...

Exchange rates force Virbac first-quarter sales dip

Virbac has seen its first-quarter sales fall year-on-year by 1% due to tough exchange rates.The French company said sales of €180.5 million ($250 million) for Q1 grew 5% on a constant currency basis. Of this gr...

Boehringer struggles in 2013 as Circoflex sales drop

Boehringer Ingelheim's animal health division recorded a 0.8% increase in sales during 2013.The firm's sales of animal health products reached €1.07 billion ($1.48 billion), which also represented a 4.5% increa...

Elanco ups bovine vaccine stake with US launch

Elanco has received US approval for a combination vaccine designed to tackle the viruses and bacteria associated with bovine respiratory disease (BRD).The US Department of Agriculture (USDA) has issued a veteri...

The Bigger Picture: Pharma splits de rigueur?

If media conjecture is to be believed, this year could end with both Merck and Novartis divesting their respective animal health units for the benefit of the wider group.Pfizer/Zoetis took the 'divide-to-streng...

Glenn David becomes acting Zoetis CFO

Glenn David, senior vice president of finance operations at Zoetis, has become the firm's acting chief financial officer.He succeeds executive vice pr...

FMD outbreak located in southern China

There has been an outbreak of foot and mouth disease (FMD) in south east China, according to the World Organisation for Animal Health (OIE).The Paris-...

Anpario benefits from tighter AGP controls

Anpario, the UK-based manufacturer of natural animal and aquaculture feed additives, has reported 12% increases in both profit and sales from its late...

Obesity prevalence plagues US pets

A new obesity report indicates the majority of US pets are overweight, with most pet owners blind to the issue.The Association for Pet Obesity Prevent...

FAO tackles North Korean FMD outbreak

A United Nations Food and Agriculture Organization (FAO) team of animal health experts has visited North Korea to advise the country on how to control...

ASKA completes animal health divestment

ASKA Animal Health, based in Tokyo, began trading as a standalone company from April 1, 2014. The company is the former animal health division of ASKA...

Ascent buys minority stake in Indian JV

Private equity investor Ascent Capital Advisors India has purchased a stake in a new animal health joint venture.Alivira Animal Health – an Indian joi...

Bioniche shareholders approve Vétoquinol bid

The long-running divestment of the Bioniche Animal Health business came to an end this week when Bioniche shareholders overwhelmingly approved the div...

Large avian flu outbreak in southern Japan

There has been a sizeable outbreak of highly pathogenic flu in south eastern Japan, according to the World Organisation for Animal Health (OIE).The Pa...

Executive Director, Animal Health Public Policy

Job Posting # POL000142, Location: Summit, NJ. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines and consumer health p...

Animal Pharm's digital era begins as the print one ends

Animal Pharm has published its last print issue. As you are reading this online, the change may be of little significance to you, but it is an important one for the brand...

Animal Pharm M&A Table 2014

The table below highlights all of the mergers and acquisitions featured in Animal Pharm in 2014 so far.The deals below are listed in order of date announced (deals announced in 2013 are not included)....

Indian JV to become operational this quarter

Alivira Animal Health, an Indian joint venture focused on the manufacture and sale of veterinary products, will become operational within the next three months.Alivira is a venture between Shasun Phar...

Meiji and Novartis launch new pet products in Japan

Tokyo-based Meiji Seika Pharma has launched the injectable anesthetic Alfaxan (alfaxalone) for cats and dogs on the Japanese market. The product is owned and manufactured by Jurox.At the same time, Me...

K-State veterinary dean Richardson to step down

Ralph C Richardson plans to leave his role as dean of the Kansas State University College of Veterinary Medicine within the next year.Dr Richardson plans to step down from the role no later than July ...

Nexvet secures $31.5m in series B funding

Australian veterinary drug developer Nexvet Biopharma has raised $31.5 million from US investors in a series B funding round.US investors Farallon Capital Management, Adage Capital Partners, Foresite ...

Boehringer funds PCV2 research with €500,000

Boehringer Ingelheim has provided independent European research into Porcine Circovirus Type 2 (PCV2) with €500,000 in support grants over the last seven years.Since 2007, the firm has awarded 20 rese...

The Influence of Feed Ingredients on Food Quality and Safety 2014

Feed additives play an ever more important role, particularly in terms their influence on animal health and growth, animal feed and human food quality and safety, and the environment.It is now widel...

Vector borne diseases: An increasing threat to One Health

Vector-borne diseases are on the increase not only amongst animals but in humans too. Animal Pharm Deputy Editor Joseph Harvey attended the canine vector-borne disease (CVBD) webconference in Barcelon...

Veterinary pharmaceutical compounding: A possible path to answers?

Three words: 'Veterinary pharmaceutical compounding'. Undoubtedly these words would likely increase the blood pressure of some Animal Pharm readers.Compounding is a hot-button topic in the industry. R...

IFAH-Europe highlights legislative changes in Europe

Major revisions to animal health legislation being considered in the EU currently offer a once in 20 years opportunity to ensure the regulations are fit for purpose. Animal Pharm editor Jamie Day spok...

Animal Health Calendar 2014

Animal Pharm's latest calendar of worldwide animal health conferences, congresses, summits and meetings during 2014 and 2015.